Why the study?
What is the long-term survival of patients with supraventricular arrhythmias undergoing closed-chest His-bundle ablation with DC shock?
What is the long-term survival of patients with supraventricular arrhythmias undergoing closed-chest His-bundle ablation with DC shock?
Closed-chest His-bundle ablation with DC shock for supraventricular arrhythmias is not associated with high short- or long-term mortality, with better survival observed in patients without underlying heart disease.
Survival after His-bundle ablation supports acceptable mortality risk in observational cohorts; leaves open comparisons to contemporary techniques.
Survival after closed‐chest ablation of His bundle with DC shock for supraventricular arrhythmias was analyzed for a 10‐year period (May 1982‐December 1992) with 317 consecutive patients (167 males, 150 females; mean age 66 years; range 33–93 years). Of these, 54 patients died (17.3%) and 5 were lost to follow‐up. The mean age at ablation was 70.3 ± 8.3 years with a range of 49–93 years. Of those who died, the mean survival was 30.5 ± 28.6 months with a range of 36 hours to 120 months; the diagnosis of heart disease was; hypertension (n = 14), cardiomyopathy (n = 8), ischemic (n = 7), valvular (n = 6). Cor pulmonale (n = 3), valvular and ischemic (n = 2). hypertension and ischemic (n = 1), miscellaneous (n = 3), and none (n = 10). Of the patients who died after ablation, the arrhythmias at the time of the ablation were atrial fibrillation (AF; n = 33), sick sinus syndrome (n = 5), atrial flutter (AFL; n = 4), paroxysmal AV junctional tachycardia (PAVJT; n = 4), AF + AFL (n = 4), atrial tachycardia (n = 2). PAVJT + AFL (n = 1), and AF + AFL + atrial tachycardia (n = 1). Death was sudden in 13 patients (25%), due to heart failure in 10 (19.2%), myocardial infarction in 4 (7.7%), stroke in 4 (7.7%). aortic vascular accident in 3 (5.8%), miscellaneous in 18 (34.6%), and undetermined in 2. The overall survival rate was 94.5% at 1 year (n = 256), 80.1% at 5 years (n = 88), 72.8% at 8 years (n = 20), and 51% at 10 years (n = 4); patients with no underlying heart disease had a better survival. DC ablation of the His bundle was not associated with a high short‐ or long‐term mortality. This study may serve as a historical review with which to compare closed‐chest ablation of the His bundle with that of other energy sources such as radiofrequency energy.
No takes yet. Share an insight, caveat, or question.
Poquet et al. (1994) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: